Key result
Preadmission statin use was not associated with a reduction in inpatient myocardial infarction following low-energy hip fracture.
Why the study?
Statins reduce MI in cardiac and vascular surgery, and MI is common in hip fracture, but whether statins decrease MI and related mortality in hip fracture surgery was unknown.
Does preadmission statin prescription reduce inpatient myocardial infarction in patients aged 65 years and above with a low-energy hip fracture?
Cohort (n=1,166)
Does preadmission statin prescription reduce inpatient myocardial infarction in patients aged 65 years and above with a low-energy hip fracture?
Preadmission statin use is not associated with a reduced risk of inpatient myocardial infarction or improved survival after MI in geriatric patients undergoing hip fracture surgery.
Answers are grounded in this paper and cite their sources.
Preadmission statin use was not associated with reduced inpatient MI after geriatric hip fracture surgery; leaves open any perioperative protective effect.
Statins have been shown to reduce myocardial infarction (MI) in cardiac and vascular surgery. MI is common in hip fracture. This study aims to investigate whether statins decrease MI in hip fracture surgery and reduce mortality resulting from MI. Patients aged 65 years and above with a low-energy hip fracture were identified between January 2015 and December 2017. Demographics, comorbidities, predictive scores, medications and outcomes were assessed retrospectively. The primary outcome was inpatient MI. The secondary outcome was inpatient mortality resulting from MI, for which fatal and non-fatal MI were modelled. Regression analysis was conducted with propensity score weighting. Hip fracture occurred in 1166 patients, of which 391 (34%) were actively taking statins. Thirty-one (2.7%) patients were clinically diagnosed with MI. They had a higher inpatient mortality than those who did not sustain an MI (35% vs. 5.3%, p < 0.0001). No reduction was seen between statin use and the occurrence of MI (OR = 0.97, 95% CI: 0.45–2.11; p = 0.942) including Fluvastatin-equivalent dosage (OR = 1.00, 95% CI: 0.96–1.03, p = 0.207). Statins were not associated with having a non-fatal MI (OR 1.47, 95% CI: 0.58-3.71; p = 0.416) or preventing fatal MI (OR = 0.40, 95% CI: 0.08–1.93; p = 0.255). Preadmission statin use and associations with clinically diagnosed inpatient MI or survival after inpatient MI were not able to be established.
No takes yet. Share an insight, caveat, or question.
Tarrant et al. (2021) conducted a cohort in Low-energy hip fracture (n=1,166). Preadmission statin use vs. No statin use was evaluated on Inpatient MI (OR 0.97, 95% CI 0.45-2.11, p=0.942). Preadmission statin use was not associated with a reduction in inpatient myocardial infarction following low-energy hip fracture.
Synapse has enriched 10 related papers. Consider them for comparative context: